Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain.
暂无分享,去创建一个
C F Rogers | R N Hiramoto | V K Ghanta | S Demissie | C M Hsueh | N S Hiramoto | J F Lorden | J. Lorden | R. Hiramoto | N. Hiramoto | V. Ghanta | C. Hsueh | C. Rogers | S. Demissie
[1] J. Owen,et al. Studies on the maturation of thymus stem cells The effects of catecholamines, histamine and peptide hormones on the expression of T cell alloantigens , 1976, European journal of immunology.
[2] T. Duka,et al. A selective distribution pattern of different opiate receptors in certain areas of rat brain as revealed by in vitro autoradiography , 1981, Neuroscience Letters.
[3] M. Draškoci,et al. Involution of Thymus and Suppression of Immune Responses in Rats treated with Reserpine , 1964, Nature.
[4] J. Dave,et al. Demonstration that corticotropin-releasing factor binding to rat peripheral tissues is modulated by glucocorticoid treatment in vivo and in vitro. , 1986, Biochemical and biophysical research communications.
[5] F. Bloom,et al. Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. , 1979, Life sciences.
[6] H. Kraemer,et al. EFFECT OF PSYCHOSOCIAL TREATMENT ON SURVIVAL OF PATIENTS WITH METASTATIC BREAST CANCER , 1989, The Lancet.
[7] K. Olness,et al. Directional changes in neutrophil adherence following passive resting versus active imagery. , 1996, The International journal of neuroscience.
[8] E. Weihe,et al. Molecular anatomy of the neuro-immune connection. , 1991, The International journal of neuroscience.
[9] Z. Grossman,et al. Neural modulation of immunity: conditioning phenomena and the adaptability of lymphoid cells. , 1992, The International journal of neuroscience.
[10] G. Martin,et al. Action of intracerebrally injected β-endorphin on the rat's core temperature , 1979 .
[11] R. Pero,et al. Psychogenic stress induces chromosomal and DNA damage. , 1996, The International journal of neuroscience.
[12] H. Solvason,et al. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta. , 1988, Journal of immunology.
[13] A. Cuello. Central distribution of opioid peptides. , 1983, British medical bulletin.
[14] H. Solvason,et al. Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB c mice , 1989, Brain, Behavior, and Immunity.
[15] J. Lorden,et al. Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US , 1994, Journal of Neuroimmunology.
[16] M. Dimitrijević,et al. Immunomodulation by conditioning: recent developments. , 1993, The International journal of neuroscience.
[17] A. Turnbull,et al. Regulation of the HPA Axis by Cytokines , 1995, Brain, Behavior, and Immunity.
[18] P. Petrusz,et al. Immunocytochemical Localization of β-Endorphin-Containing Neurons in the Rat Brain , 1981 .
[19] R. Goodman,et al. Differentiation of delta and mu opiate receptor localizations by light microscopic autoradiography. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Stein. A reconsideration of specificity in psychosomatic medicine: from olfaction to the lymphocyte. , 1986, Psychosomatic medicine.
[21] Steven F. Maier,et al. Psychoneuroimmunology. The interface between behavior, brain, and immunity. , 1994, The American psychologist.
[22] J. Gauldie,et al. The acute phase response. , 1994, Immunology today.
[23] E. Lumpkin,et al. Adrenocorticotropin stimulates natural killer cell activity. , 1991, Endocrinology.
[24] R. Hiramoto,et al. Expression of the conditioned NK cell activity is β-endorphin dependent , 1995, Brain Research.
[25] S. Soong,et al. A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapy. , 1993, The International journal of neuroscience.
[26] Z. Stojic,et al. Effect of dopamine, L-dopa, carbidopa and L-dopa/carbidopa on arthus and delayed hypersensitivity skin reactions in the rat. , 1991, International Journal of Neuroscience.
[27] K. Kovács,et al. Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. , 1987, Neuroendocrinology.
[28] J. Lorden,et al. The use of conditioning to probe for CNS pathways that regulate fever and NK cell activity. , 1996, The International journal of neuroscience.
[29] N. Appel,et al. Mu receptors at discrete hypothalamic and brainstem sites mediate opioid peptide-induced increases in central sympathetic outflow , 1986, Brain Research.
[30] C. Dinarello. Interleukin-1 and the pathogenesis of the acute-phase response. , 1984, The New England journal of medicine.
[31] H. Solvason,et al. The identity of the unconditioned stimulus to the central nervous system is interferon-β , 1993, Journal of Neuroimmunology.
[32] H. Solvason,et al. A Simple, Single, Trial-Learning Paradigm for Conditioned Increase in Natural Killer Cell Activity , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[33] W. Pierpaoli. Pineal grafting and melatonin induce immunocompetence in nude (athymic) mice. , 1993, The International journal of neuroscience.
[34] W. L. Dees,et al. Induction by cytokines of the pattern of pituitary hormone secretion in infection. , 1994, Neuroimmunomodulation.
[35] R. Ader,et al. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. , 1982, Science.
[36] J. Dayer,et al. Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? , 1984, Journal of immunology.
[37] E. O. Johnson,et al. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. , 1989, Endocrinology.
[38] A. Goldstein,et al. Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmitters. , 1985, Journal of immunology.
[39] D. Lysle,et al. Stressor-induced changes in mitogenic activity are not associated with decreased interleukin 2 production or changes in lymphocyte subsets. , 1991, Clinical immunology and immunopathology.
[40] A. Arimura,et al. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1 beta-induced ACTH release. , 1990, The American journal of physiology.
[41] S. Klosterhalfen,et al. Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats. , 1983, Behavioral neuroscience.
[42] W. Vale,et al. Identification of corticotropin-releasing factor (CRF) target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF. , 1986, Endocrinology.
[43] R. Hiramoto,et al. Indomethacin and sodium carbonate effects on conditioned fever and NK cell activity , 1992, Pharmacology Biochemistry and Behavior.
[44] R. Hiramoto,et al. Activation of μ-opioid receptors are required for the conditioned enhancement of NK cell activity , 1996, Brain Research.
[45] J. Wamsley. Opioid receptors: autoradiography. , 1983, Pharmacological reviews.
[46] R. Hiramoto,et al. Effect of dexamethasone on conditioned enhancement of natural killer cell activity. , 1994, Neuroimmunomodulation.
[47] Jeffrey P. Pascoe,et al. Learning and Memory: Vertebrate Models , 1991 .
[48] G. Fillion,et al. Receptors for interleukin-1 (α and β) in mouse brain: Mapping and neuronal localization in hippocampus , 1991, Neuroscience.
[49] R. Hiramoto,et al. The direction of the conditioned natural killer cell response can be re-directed with indomethacin and/or handling. , 1992, The International journal of neuroscience.
[50] E. Sorkin,et al. Immunoregulation mediated by the sympathetic nervous system, II. , 1979, Cellular immunology.
[51] C. Blatteis,et al. Hypothalamic neuronal responses to interleukin-6 in tissue slices: Effects of indomethacin and naloxone , 1992, Brain Research Bulletin.
[52] R. Hiramoto,et al. Conditioning the elevation of body temperature, a host defensive reflex response. , 1991, Life sciences.
[53] P. Petrusz,et al. The immunocytochemical localization of enkephalin in the central nervous system of the rat , 1981, The Journal of comparative neurology.
[54] D. Lysle,et al. Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement , 1994, Journal of Neuroimmunology.
[55] L. Weiner,et al. The Role of Opioid Peptides in Immunomodulation a , 1990, Annals of the New York Academy of Sciences.
[56] J. Lorden,et al. Effect of reserpine on retention of the conditioned NK cell response , 1990, Pharmacology Biochemistry and Behavior.
[57] A. Arimura,et al. Interleukin-1β activation of the central nervous system , 1992 .
[58] W. Markesbery,et al. Hypothalamic-immune interactions. II. The effect of hypothalamic lesions on the ability of adherent spleen cells to limit lymphocyte blastogenesis. , 1982, Immunology.
[59] S. Lightman,et al. Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin a messenger RNA , 1989, Neuropeptides.
[60] R. Gorczynski. Analysis of lymphocytes in, and host environment of, mice showing conditioned immunosuppression to cyclophosphamide , 1987, Brain, behavior, and immunity.
[61] J. Lorden,et al. Identification of specific pathways of communication between the CNS and NK cell system. , 1993, Life sciences.
[62] D. Jackson. A hypothalamic region responsive to localized injection of pyrogens. , 1967, Journal of neurophysiology.
[63] S. Soong,et al. Conditioning of the allogeneic cytotoxic lymphocyte response , 1993, Pharmacology Biochemistry and Behavior.
[64] W. Markesbery,et al. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. , 1986, Immunology.
[65] R. Hiramoto,et al. Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity , 1995, Journal of Neuroimmunology.
[66] H. Solvason,et al. Conditioning: a new approach to immunotherapy. , 1990, Cancer research.
[67] P. Wood,et al. μ-, δ-, κ- and ϵ-Opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides , 1987, Brain Research.
[68] H. Haas,et al. Hypothalamic changes during the immune response. , 1977, European journal of immunology.
[69] H SELYE,et al. [General adaptation syndrome and diseases of adaptation]. , 1946, L'union medicale du Canada.
[70] J. N. Langley. THE AUTONOMIC NERVOUS SYSTEM , 1903 .
[71] N. Appel,et al. beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons. , 1986, The Journal of pharmacology and experimental therapeutics.
[72] Branislav D. Janković,et al. Neuro-Endocrine Correlates of Immune Response , 1973 .
[73] A. Husband,et al. Acute-phase immune response: Lipopolysaccharide-induced fever and sleep alterations are not simultaneously conditionable in the rat during the inactive (light) phase , 1994, Physiology & Behavior.
[74] S. Tyring,et al. Efferent signal(s) responsible for the conditioned augmentation of natural killer cell activity. , 1994, Neuroimmunomodulation.
[75] R. Hiramoto,et al. The central effect of methionine-enkephalin on NK cell activity , 1992, Brain Research.
[76] S. Felten,et al. Innervation of Lymphoid Tissue , 1991 .